Not for human consumption, veterinary use, or clinical administration. Sold exclusively to qualified laboratories and researchers for in-vitro study.
Retatrutide is a synthetic 39-amino-acid peptide with simultaneous affinity for three receptors: GLP-1, GIP and glucagon. It is built on a GIP-based backbone, carries α-aminoisobutyric acid (Aib) at position 2 and a C20 fatty-diacid side chain that extends its pharmacokinetic profile through albumin binding. The research literature lists a molecular weight of 4,731.33 Da, the formula C221H342N46O68 and CAS number 2381089-83-2.
The compound is studied in preclinical research on multi-receptor incretin and glucagon signalling, on receptor binding kinetics and on comparative pharmacology against earlier single and dual agonists. Its triple-receptor design is the reason it has become a reference compound in current metabolic-signalling research. In the research community it is often shortened to "reta".
The same retatrutide is also offered as the Reta Pen, a pre-filled pen with click mechanism in 10 mg, 20 mg and 30 mg, as Reta Duo two-vial packs in 10 mg and 20 mg, and as the Reta Triplet of three 10 mg research kits. Laboratories that want to calculate the concentration produced by a given volume of diluent can use the peptide reconstitution calculator.
Retatrutide ships within Europe, including Ireland, and every parcel is tracked. Customers in Ireland can pay by card, PayPal, Klarna or SEPA transfer; other European countries see their local payment options at checkout. Our support team answers questions about batches, certificates and order status before and after purchase.
Retatrutide is sold strictly for laboratory research use only and is not for human consumption. myPEPT makes no medical claims and does not give legal advice; buyers confirm at checkout that they are purchasing for research purposes and are responsible for compliance with the rules that apply to them.
For research use only. This product is intended exclusively for in-vitro research and laboratory applications. Not approved for human or animal consumption, medical treatment, or therapeutic use.
For research use only. This product is intended exclusively for in-vitro research and laboratory applications. Not approved for human or animal consumption, medical treatment, or therapeutic use. Retatrutide is an investigational compound without marketing authorisation. It is listed on the WADA Prohibited List.
